|1|Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy. (24429497)
Berenson J.R.... Vescio R.A.
|2|Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma. (23671753)
Robles A.... MagnAc N.
|3|BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma. (24141333)
Bolkun L.... Dzieciol J.
|4|Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. (24248686)
Kapoor P.... Gertz M.A.
|5|Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. (23939198)
Costa L.J.... Hari P.N.
|6|Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy. (23144198)
Coman T.... Rubio M.T.
|7|Tubular nuclear accumulation of Snail and epithelial phenotypic changes in human myeloma cast nephropathy. (21315411)
Hertig A.... Xu-Dubois Y.C.
|8|Integrin I^7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. (21474670)
Neri P.... Bahlis N.J.
|9|BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma. (21063407)
Bodet L.... Gomez-Bougie P.
|10|Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. (19302404)
Yuregir O.O.... Sahin F.I.
|11|Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells. (19914305)
LA^pez-Royuela N.... Naval J.
|12|Short or long survival in multiple myeloma. A simple method for determining the prognosis. (19052918)
VA!rkonyi J.... KarA!di I.
|13|CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis. (17767956)
Bataille R.... Moreau P.
|14|Neoadjuvant therapy in a patient with clival plasmacytoma associated with multiple myeloma: a case report. (18291467)
Yamaguchi S.... Iwasaki Y.
|15|Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism. (18846331)
Kong F.... Zou P.
|16|The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. (17942756)
Lauring J.... Park B.H.
|17|JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones. (19129688)
Kuroda J.... Taniwaki M.
|18|Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors. (16385588)
Ding J.... Ueda N.
|19|Bone destruction in multiple myeloma. (16831932)
Matsumoto T.... Abe M.
|20|Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma. (16193335)
Zhou F.L.... Liu S.H.
|21|New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway. (16454747)
van de Donk N.W.... Lokhorst H.M.
|22|The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression]. (16875552)
Guo Y.Q.... Chen S.L.
|23|Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. (15638855)
Andersen N.F.... Abildgaard N.
|24|Immunomodulation of multiple myeloma. (15640623)
Tohnya T.M.... Figg W.D.
|25|Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. (15491288)
Otsuki T.... Sugihara T.
|26|Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. (15070700)
Bharti A.C.... Aggarwal B.B.
|27|Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C. (15550207)
Petrucca A.... Nicoletti M.
|28|New insights into the pathophysiology of multiple myeloma. (12965277)
Seidl S.... Drach J.
|29|Fibrinolytic activity in multiple myeloma. (14635202)
YaA9ci M.... Haznedar R.
|30|Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma. (11940209)
Kitazawa R.... Maeda S.
|31|Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma. (11918538)
Zeis M.... Uharek L.
|32|Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. (11468182)
Grad J.M.... Boise L.H.
|33|High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. (11524732)
Bezieau S.... Bataille R.
|34|Interleukin-10 gene promoter polymorphisms in multiple myeloma. (11307152)
Zheng C.... Sundblad A.
|35|Smoldering, asymptomatic stage 1, and indolent myeloma. (12057049)
|36|Interferon in multiple myeloma--summary of treatment results and clinical implications. (11145439)
Ludwig H.... Fritz E.
|37|CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytolysis. (10891455)
Shallal S.... Kornbluth J.
|38|Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes. (9558394)
PAcrez-SimA^n J.A.... OrfALo A.
|39|Taxol can induce phosphorylation of BCL-2 in multiple myeloma cells and potentiate dexamethasone-induced apoptosis. (9619919)
Kroning R.... Lichtenstein A.
|40|Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. (9815779)
Ogata A.... Anderson K.C.
|41|Serum oncostatin M in multiple myeloma: association with prognostic factors. (9012701)
Koskela K.... Pulkki K.
|42|Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. (8695815)
Chesi M.... Kuehl W.M.
|43|Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma. (8635126)
Raina V.... Bhargava M.
|44|Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. (7591683)
Cohen A.M.... Manor Y.
|45|The role of interferon-alpha in the treatment of multiple myeloma]. (7699901)
|46|Alternating combination chemotherapy and interferon improves survival in poor prognosis multiple myeloma. (7542473)
AvilAcs A.... Rosas A.
|47|Plasma prekallikrein, coagulation and fibrinolytic parameters in myeloma patients. (1502028)
Annichino-Bizzacchi J.M.... Sampaio C.A.
|48|Rapid disappearance of M-protein in multiple myeloma complicated by pneumonia during treatment with HLBI]. (1479692)
Ashihara E.... Nakamura M.
|49|DDAVP in acquired von Willebrand syndrome associated with multiple myeloma. (3088986)
Takahashi H.... Shibata A.
|50|Localized and indolent myeloma. (7407416)